Medical/Pharmaceuticals
Positive Interim Efficacy Data from GDC-0084 Phase II Study in Glioblastoma Released at SNO Conference
SYDNEY, Nov. 25, 2019 /PRNewswire/ -- Kazia Therapeutics Limited (ASX: KZA; NASDAQ: KZIA), an Australian oncology-focused biotechnology company, is pleased to share with investors interim data from its ongoing phase II study of GDC-0084 in glioblastoma, the most common and most aggressive form of...
2019-11-25 07:00
2098
WuXi Vaccines to Build a $240 Million Manufacturing Facility in Ireland
DUNDALK, Ireland, Nov. 23, 2019 /PRNewswire/ -- WuXi Biologics ("WuXi Bio") (2269.HK), a leading global open-access biologics technology platform company offering end-to-end solutions for biologics discovery, development, and manufacturing, announced that its subsidiary WuXi Vaccines, engaged in ...
2019-11-23 01:55
5342
Patient Enrollment Completed in Phase III Clinical Study of Adapalene-Clindamycin Combination Gel in China
BEIJING, Nov. 22, 2019 /PRNewswire/ -- China Ophthalmology Focus Limited ("COPFL") today announced that its wholly-owned subsidiary, Zhaoke (Guangzhou) Ophthalmology Pharmaceutical Limited ("ZKO") has successfully completed patient enrollment of the Phase III study of Adapalene-Clindamycin Combin...
2019-11-22 23:50
3418
Guardant Health AMEA wins this year's Growth Excellence Leadership Award by Frost & Sullivan
SINGAPORE, Nov. 22, 2019 /PRNewswire/ -- Guardant Health AMEA has won Frost & Sullivan's Growth Excellence Leadership Award under the Best Practices Category for 2019 Asia-Pacific Liquid Biopsy for Precision Oncology. "We are delighted to receive this prestigious award from Frost & Sullivan. T...
2019-11-22 15:37
1662
Thrombosis Research Institute (TRI) Launches Innovative Risk Calculator for Predicting Stroke, Major Bleeding and Mortality in Atrial Fibrillation Over Two Years
- Rapidly predicts differences in risk when treated with different anticoagulants or not treated - Crucially, risk is calculated using patient-specific measurements rather than standardised measures, providing personalised results - Underscored by data of 52,000 AF patients and externally vali...
2019-11-21 23:05
2662
Global Cord Blood Corporation to Report Second Quarter and First Half Fiscal 2020 Financial Results
HONG KONG, Nov. 21, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today announced that it plans to release unaudited financia...
2019-11-21 20:00
5910
Global Cord Blood Corp Comments on New Regulation
HONG KONG, Nov. 20, 2019 /PRNewswire/ -- Global Cord Blood Corporation (NYSE: CO) (the "Company"),China's leading provider of cord blood collection, laboratory testing, hematopoietic stem cell processing and stem cell storage services, today commented on a new regulation related to companies in ...
2019-11-20 20:00
5562
NeuroVive Pharmaceutical AB Interim Report January - September 2019
STOCKHOLM, Nov. 20, 2019 /PRNewswire/ -- Important events July - September * NeuroVive initiates second part of its ongoing KL1333 Phase Ia/b clinical study * NeuroSTAT receives Fast Track designation from the US Food and Drug Administration. Financial information third quarter (July-Septem...
2019-11-20 16:38
3902
Covance Receives 2019 Global CRO Customer Value Leadership Award from Frost & Sullivan
SINGAPORE, Nov. 20, 2019 /PRNewswire/ -- Covance was honored with the 2019 Global CRO Customer Value Leadership award from Frost & Sullivan at the annual Frost & Sullivan Asia-Pacific Best Practices Awards banquet held inSingapore on 14 November 2019. Frost & Sullivan firmly believes Covance's e...
2019-11-20 15:52
1047
Cambridge Quantum Computing Achieves Groundbreaking Results in Quantum Chemistry
CQC gets VQE "off the ground" and provides an efficient route towards simulating excited molecules using quantum computers CAMBRIDGE, England, Nov. 20, 2019 /PRNewswire/ -- Cambridge Quantum Computing ("CQC") today announced an important breakthrough in quantum chemistry that will enhance and ac...
2019-11-20 15:00
2285
Merck Announces Orphan Drug Designation for Investigational Therapy Tepotinib in Patients with NSCLC Harboring MET Gene Alterations
- Japanese Ministry of Health, Labour and Welfare grants orphan drug designation for diseases that affect fewer than 50,000 patients inJapan, and for which significant unmet medical need exists - MET exon 14 (METex14) skipping alterations and MET amplifications are present in 3-5% of non-small c...
2019-11-20 15:00
2252
CStone announces first patient dosed in the Phase I bridging registrational study of ivosidenib
SUZHOU, China, Nov. 20, 2019 /PRNewswire/ -- CStone Pharmaceuticals ("CStone" or the "Company", HKEX: 2616) today announced that the first patient has been dosed in the Phase I bridging registrational study of ivosidenib (TIBSOVO®) in China. This stand-alone trial is designed to validate the effi...
2019-11-20 11:41
2247
Excelra Announces a Drug Repurposing Collaboration With Maruho On Dermatological Applications
HYDERABAD, India, Nov. 20, 2019 /PRNewswire/ -- Excelra, a leading global Data and Analytics Company today announced a Drug Repurposing collaboration withOsaka -based Maruho – a pharmaceutical company specialising in Dermatology. Under the agreement, the Drug Repurposing Data Scientists and Therap...
2019-11-20 10:00
2157
Potential New Biomarkers for Parkinson's Disease Could Change Trajectory of Diagnosis and Treatment
LONDON, Nov. 20, 2019 /PRNewswire/ -- World Federation of Neurology: A groundbreaking presentation coming out of theXXIV World Congress of Neurology (WCN 2019) inDubai, UAE, highlighted several significant advances in Parkinson's research. "We are beginning to understand Parkinson's disease mech...
2019-11-20 02:27
1028
Pregnancy No Longer Believed to Modify Trajectory of MS, Experts Say
LONDON, Nov. 18, 2019 /PRNewswire/ -- World Federation of Neurology — For women living with MS, pregnancy, and breastfeeding were once thought to slow the progression of the disease. During theXXIV World Congress of Neurology (WCN 2019) inDubai, UAE, which took place Oct. 27-31, 2019, experts re...
2019-11-18 23:30
1393
The Prognosis for MS is Changing Due to Advancements in Treatment and Awareness, Yet Access to Care is Top of Mind for Global Neurologists
LONDON, Nov. 18, 2019 /PRNewswire/ -- World Federation of Neurology: Are regulators keeping up with new treatments and management strategies that can greatly improve the lives of patients with multiple sclerosis (MS)? That question is being debated following the unveiling of significant clinical ...
2019-11-18 23:28
1337
Clarity Engagement Solutions announces the appointment of Kevin Simpson as CEO
DUBLIN, Nov. 18, 2019 /PRNewswire/ -- Clarity Engagement Solutions, a leading provider of performance consulting, training and execution in the life sciences, medical device and corporate and institutional banking industries today announced that the Company's Board of Directors has appointedKevin...
2019-11-18 23:26
1789
RhoVac Reports Interim Results on Immunological Response with RV001
STOCKHOLM, Nov. 18, 2019 /PRNewswire/ -- Today, 18th November 2019, RhoVac AB ("RhoVac") reports interim results from ongoing immunological studies at University of Tübingen,Germany concluding that treatment with RV001 can activate CD4+ T-cells and also CD8+ T-cells. In July 2019 RhoVac publishe...
2019-11-18 17:13
1070
BioDuro chooses SciFinder-n from CAS to enhance research productivity and shorten cycle times for client success
Collaboration between drug companies and contract research partners drives innovation in evolving business environment COLUMBUS, Ohio, Nov. 18, 2019 /PRNewswire/ -- CAS, a division of the American Chemical Society, announced today that leading contract research, development and manufacturing org...
2019-11-18 08:15
2598
Unprecedented Gathering of Asia Pacific Medical Societies to Respond to the Impact of Antibiotic Resistance on All People
BANGKOK, Nov. 17, 2019 /PRNewswire/ -- In anticipation of World Antibiotic Awareness Week (18-24 November) the Antimicrobial Resistance (AMR) Summit Expert Group and the Antimicrobial Stewardship (AMS) Working Group convened in Bangkok, Thailand, in a first-ever regional effort to combat the 'sile...
2019-11-17 12:00
2278
Week's Top Stories
Most Reposted
Thailand Tops 2024 Consumer Review Awards by Agoda
[Picked up by 329 media titles]
2024-09-26 11:00
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
[Picked up by 314 media titles]
2024-09-26 00:00
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
[Picked up by 312 media titles]
2024-09-23 13:37
Circles Partners with Telkomsel, Providing an Advanced Software-as-a-Service (SaaS) Platform to Enhance Customer Digital Experience
[Picked up by 297 media titles]
2024-09-27 10:00RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
[Picked up by 294 media titles]
2024-09-23 22:00
Most Read
RuggON Debuts at the Largest Mining Expo, MINExpo 2024 Showcasing Rugged Solutions for the Trillion-Dollar Mining Market
2024-09-23 22:00
6930
WARHAMMER 40,000: SPACE MARINE VR - DEFENDERS OF AVARAX NOW AVAILABLE AT ZERO LATENCY VR VENUES WORLDWIDE
2024-09-26 00:00
6443
Advantech Unveils Expanded Singapore Office to Boost ASEAN Presence and Support AIoT Innovations with Strategic Partnerships
2024-09-23 13:37
6314
Sobot Reflects on its Partnership with Lilith Games on Lilith's 11th Anniversary
2024-09-24 10:00
5537
Thailand Tops 2024 Consumer Review Awards by Agoda
2024-09-26 11:00
5257